JDRF to Honor AdvaMed at the 2022 Mid-Atlantic Hope Gala
On November 5th, 2022, the JDRF Mid-Atlantic Chapter will honor the world’s leading medical technology trade organization, AdvaMed, based in Washington, D.C., at the JDRF Mid-Atlantic Hope Gala at the MGM National Harbor in Oxon Hill, MD. AdvaMed is being recognized for its wholehearted support of JDRF’s mission and its dedication to solving the world’s most pressing health challenges.
Advances in medical technologies have a major impact on the lives of those living with chronic diseases. For individuals with type 1 diabetes (T1D), the advancements made over the past 50 years with T1D-related technology have significantly improved diabetes management and quality of life, while simultaneously reducing disease-related complications. The first insulin pumps were so large that they had to be worn as backpacks. Now, not only can insulin pumps fit in a pocket but many also are capable of operating on a closed-loop system, too. As the largest medical technology device association in the world, AdvaMed recognizes the critical role that medical technology plays in saving lives. Its more than 450 member companies, from small startups to multinational companies, commit to developing the best tools to diagnose and treat patients around the globe.
With patients at the heart of its members’ work, AdvaMed is dedicated to using advocacy to ensure that medical technologies are accessible to all patients. “JDRF’s extraordinary work over the decades has dramatically changed the lives of those living with type 1 diabetes,” said Scott Whitaker, AdvaMed President and CEO, whose daughter has been living with T1D for twelve years. “JDRF’s partnership with AdvaMed has been critically important to T1D patients. We thank them for their hard work with our companies as well as with key policymakers and regulators, to ensure patients everywhere have access to our companies’ life-changing diabetes technologies.”
This year’s JDRF Hope Gala, chaired by Wanda Forrest and Rich Lucas, will bring together more than 800 philanthropic community leaders to raise critical funds for research to cure, prevent, and treat T1D. The black-tie affair will feature a cocktail reception, seated dinner, silent and live auctions, and outstanding entertainment.